Compare SLDB & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | LXU |
|---|---|---|
| Founded | 2013 | 1968 |
| Country | United States | United States |
| Employees | N/A | 513 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 880.5M |
| IPO Year | 2017 | 2006 |
| Metric | SLDB | LXU |
|---|---|---|
| Price | $8.70 | $11.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | ★ $16.36 | $14.63 |
| AVG Volume (30 Days) | ★ 751.6K | 661.3K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.97 | ★ 225.93 |
| EPS | N/A | ★ 0.18 |
| Revenue | $8,094,000.00 | ★ $615,208,000.00 |
| Revenue This Year | N/A | $13.69 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $65.00 |
| Revenue Growth | N/A | ★ 17.77 |
| 52 Week Low | $3.79 | $7.71 |
| 52 Week High | $11.45 | $17.22 |
| Indicator | SLDB | LXU |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 62.08 |
| Support Level | $6.25 | $11.54 |
| Resistance Level | $11.45 | $12.39 |
| Average True Range (ATR) | 0.42 | 0.49 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 14.18 | 79.79 |
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.